Cargando…
A disintegrin and metalloproteinase 17 mRNA and protein expression in esophageal squamous cell carcinoma, as well as its clinicopathological factors and prognosis
The aim of the present study was to explore a disintegrin and metalloproteinase 17 (ADAM17) mRNA and protein expression in esophageal squamous cell carcinoma and its association with clinicopathological factors and prognosis. Through semi-quantitative reverse transcription polymerase chain reaction,...
Autores principales: | LIU, HONG-BIN, YANG, QI-CHANG, SHEN, YI, ZHU, YAN, ZHANG, XIAO-JUAN, CHEN, HAO |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
D.A. Spandidos
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4262481/ https://www.ncbi.nlm.nih.gov/pubmed/25351873 http://dx.doi.org/10.3892/mmr.2014.2802 |
Ejemplares similares
-
The disintegrin-metalloproteinases ADAM10 and ADAM17 are upregulated in cutaneous squamous cell carcinomas
por: Oh, S.-T., et al.
Publicado: (2016) -
Diagnostic and prognostic value of a disintegrin and metalloproteinase-17 in patients with gliomas
por: WU, BIN, et al.
Publicado: (2014) -
Molecular switch in human diseases-disintegrin and metalloproteinases, ADAM17
por: Yang, Guang, et al.
Publicado: (2021) -
A-Disintegrin and Metalloproteinase (ADAM) 17 Enzymatically Degrades Interferon-gamma
por: Kanzaki, Hiroyuki, et al.
Publicado: (2016) -
Potential role of a disintegrin and metalloproteinase-17 (ADAM17) in age-associated ventricular remodeling of rats
por: Liu, Hainiang, et al.
Publicado: (2019)